Abstract:In vascular smooth muscle cells (VSMCs), platelet-derived growth factor (PDGF) plays a major role in inducing phenotypic switching from contractile to proliferative state. Importantly, VSMC phenotypic switching is also determined by the phosphorylation state/expression levels of insulin receptor substrate (IRS), an intermediary signaling component that is shared by insulin and IGF-I. To date, the roles of PDGF-induced key proliferative signaling components including Akt, p70S6kinase, and ERK1/2 on the serine phosphorylation/expression of IRS-1 and IRS-2 isoforms remain unclear in VSMCs. We hypothesize that PDGF-induced VSMC proliferation is associated with dysregulation of insulin receptor substrates. Using human aortic VSMCs, we demonstrate that prolonged PDGF treatment led to sustained increases in the phosphorylation of protein kinases such as Akt, p70S6kinase, and ERK1/2, which mediate VSMC proliferation. In addition, PDGF enhanced IRS-1/IRS-2 serine phosphorylation and downregulated IRS-2 expression in a time- and concentration-dependent manner. Notably, phosphoinositide 3-kinase (PI 3-kinase) inhibitor (PI-103) and mammalian target of rapamycin inhibitor (rapamycin), which abolished PDGF-induced Akt and p70S6kinase phosphorylation, respectively, blocked PDGF-induced IRS-1 serine phosphorylation and IRS-2 downregulation. In contrast, MEK1/ERK inhibitor (U0126) failed to block PDGF-induced IRS-1 serine phosphorylation and IRS-2 downregulation. PDGF-induced IRS-2 downregulation was prevented by lactacystin, an inhibitor of proteasomal degradation. Functionally, PDGF-mediated IRS-1/IRS-2 dysregulation resulted in the attenuation of insulin-induced IRS-1/IRS-2-associated PI 3-kinase activity. Pharmacological inhibition of PDGF receptor tyrosine kinase with imatinib prevented IRS-1/IRS-2 dysregulation and restored insulin receptor signaling. In conclusion, strategies to inhibit PDGF receptors would not only inhibit neointimal growth but may provide new therapeutic options to prevent dysregulated insulin receptor signaling in VSMCs in nondiabetic and diabetic states.

Platelet Derived Growth Factor Regulates ABCA1 Expression in Vascular Smooth Muscle Cells

ABCA1 Inhibits PDGF‐induced Proliferation and Migration of Rat Airway Smooth Muscle Cell Through Blocking TLR2/NF‐κB/NFATc1 Signaling

Platelet-deriver Growth Factor Stimulates Vascular Smooth Muscle Cell Proliferation Through AKT-FoxO Signaling Pathway

Pgc-1 Alpha Inhibits Oleic Acid Induced Proliferation And Migration Of Rat Vascular Smooth Muscle Cells

Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity

Regulation of ABCA1 on the expression of inflammatory cytokines in human vascular smooth muscle cells and its clinical significance

Two Platelet-derived Growth Factor Receptors in Vascular Smooth Muscle Cells.

Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3β Phosphorylation*

Growth Differentiation Factor-15 Induces Expression of ATP-binding Cassette Transporter A1 Through PI3-K/PKCζ/SP1 Pathway in THP-1 Macrophages

[Role of Rac1 Activation in Platelet Derived Growth Factor-Bb Induced Proliferation and Migration in Rat Aortic Smooth Muscle Cells].

Visceral Adipose Tissue-Derived Serine Protease Inhibitor Accelerates Cholesterol Efflux by Up-Regulating ABCA1 Expression Via the NF-κB/miR-33a Pathway in THP-1 Macropahge-Derived Foam Cells

TGF-&beta;1 Up-Regulates Expression of ABCA1, ABCG1 and SR-BI Through Liver X Receptor &alpha; Signaling Pathway in THP-1 Macrophage-Derived Foam Cells

Differential Roles of PDGFR‐α and PDGFR‐β in Angiogenesis and Vessel Stability

Effects of ABCA1 on Human Aortic Smooth Muscle Cells' Inflammatory Cytokines Induced by Oxidized Low Density Lipoprotein

PDGF-induced Vascular Smooth Muscle Cell Proliferation is Associated with Dysregulation of Insulin Receptor Substrates.

Transforming Growth Factor β Inhibits Platelet Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation via Akt-Independent, Smad-Mediated Cyclin D1 Downregulation

PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways.

Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways

Peroxisome Proliferator-Activated Receptor Delta is Up-Regulated During Vascular Lesion Formation and Promotes Post-Confluent Cell Proliferation in Vascular Smooth Muscle Cells

Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice

Platelet-Derived Growth Factor Induces Rad Expression Through Egr-1 In Vascular Smooth Muscle Cells